Mechanisms governing the inflammatory response during sepsis have been shown to be complex, involving cross-talk between diverse signaling pathways. Current knowledge regarding the mechanisms underlying sepsis provides an incomplete picture of the syndrome, justifying additional efforts to understand this condition. Microarray-based expression profiling is a powerful approach for the investigation of complex clinical conditions such as sepsis. In this study, we investigate whole-genome expression profiles in mononuclear cells from survivors (n = 5) and non-survivors (n = 5) of sepsis. To circumvent the heterogeneity of septic patients, only patients admitted with sepsis caused by community-acquired pneumonia were included. Blood samples were collected at the time of sepsis diagnosis and seven days later to evaluate the role of biological processes or genes possibly involved in patient recovery. Principal Components Analysis (PCA) profiling discriminated between patients with early sepsis and healthy individuals. Genes with differential expression were grouped according to Gene Ontology, and most genes related to immune defense were up-regulated in septic patients. Additionally, PCA in the early stage was able to distinguish survivors from non-survivors. Differences in oxidative phosphorylation seem to be associated with clinical outcome because significant differences in the expression profile of genes related to mitochondrial electron transport chain (ETC) I–V were observed between survivors and non-survivors at the time of patient enrollment. Global gene expression profiles after seven days of sepsis progression seem to reproduce, to a certain extent, patterns collected at the time of diagnosis. Gene expression profiles comparing admission and follow-up samples differed between survivors and non-survivors, with decreased expression of genes related to immune functions in non-survivors. In conclusion, genes related to host defense and inflammatory response ontology were up-regulated during sepsis, consistent with the need for a host response to infection, and the sustainability of their expression in follow-up samples was associated with outcomes.
References
[1]
Bone RC, Balk RA, Cerra FB, Dellinger PR, Fein AM, et al. (1992) Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. Chest 101: 1644–1655. doi: 10.1378/chest.101.6.1644
[2]
Salomao R, Brunialti MKC, Rapozo MM, Baggio-Zappia GL, Galanos C, et al. (2012) Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock 38: 227–242. doi: 10.1097/shk.0b013e318262c4b0
[3]
Bone R (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24: 1125–1128. doi: 10.1097/00003246-199607000-00010
[4]
Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13: 260–268. doi: 10.1016/s1473-3099(13)70001-x
[5]
Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369: 840–851. doi: 10.1056/nejmra1208623
[6]
Wong HR (2012) Clinical review: sepsis and septic shock-the potential of gene arrays. Crit Care 16: 204. doi: 10.1186/cc10537
[7]
Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032–1037. doi: 10.1038/nature03985
[8]
Talwar S, Munson PJ, Barb J, Fiuza C, Cintron AP, et al. (2006) Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics 25: 203–215. doi: 10.1152/physiolgenomics.00192.2005
[9]
Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, Barrette TR, Shankar-Sinha S, et al. (2001) Gene Expression Profiles of Systemic Inflammation. Am J Pathol 159: 1199–1209. doi: 10.1016/s0002-9440(10)62505-9
[10]
Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC (2007) The Use of Gene-Expression Profiling to Identify Candidate Genes in Human Sepsis. Am J Respir Crit Care Med 176: 676–684. doi: 10.1164/rccm.200612-1819oc
[11]
Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, et al. (2006) Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett 106: 63–71. doi: 10.1016/j.imlet.2006.04.010
[12]
Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC (2009) Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 37: 882–888. doi: 10.1097/ccm.0b013e31819b52fd
[13]
Tang BM, Huang SJ, McLean AS (2010) Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care 14: R237. doi: 10.1186/cc9392
[14]
Russell JA (2011) Gene expression in human sepsis: what have we learned? Crit Care 15: 121. doi: 10.1186/cc9384
[15]
Tang BMP, McLean AS, Dawes IW, Huang SJ, Cowley MJ, et al. (2008) Gene-expression profiling of gram-positive and gram-negative sepsis in critically ill patients. Crit Care Med 36: 1125–1128. doi: 10.1097/ccm.0b013e3181692c0b
[16]
Foster SL, Hargreaves DC, Medzhitov R (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972–978. doi: 10.1038/nature05836
[17]
Del Fresno C, García-Rio F, Gómez-Pi？a V, Soares-Schanoski A, Fernández-Ruíz I, et al. (2009) Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 182: 6494–6507. doi: 10.4049/jimmunol.0803350
[18]
Janeway CA, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20: 197–216. doi: 10.1146/annurev.immunol.20.083001.084359
[19]
Salom？o R, Martins PS, Brunialti MKC, Fernandes MDL, Martos LSW, et al. (2008) TLR signaling pathway in patients with sepsis. Shock 30: 73–76. doi: 10.1097/shk.0b013e318181af2a
[20]
Salomao R, Brunialti MKC, Gomes E, Mendes ME, Diaz RS, et al. (2009) Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock. Crit Care Med 37: 132–139. doi: 10.1097/ccm.0b013e318192fbaf
[21]
Blackwell TS, Christman JW (1997) The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 17: 3–9. doi: 10.1165/ajrcmb.17.1.f132
[22]
Eto A, Muta T, Yamazaki S, Takeshige K (2003) Essential roles for NF-κB and a Toll/IL-1 receptor domain-specific signal(s) in the induction of IκB-ζ. Biochem Biophys Res Commun 301: 495–501. doi: 10.1016/s0006-291x(02)03082-6
[23]
Villar J, Pérez-Méndez L, Flores C, Maca-Meyer N, Espinosa E, et al. (2007) A CXCL2 polymorphism is associated with better outcomes in patients with severe sepsis. Crit Care Med 35: 2292–2297. doi: 10.1097/01.ccm.0000284511.73556.59
[24]
Alves-Filho JC, Spiller F, Cunha FQ (2010) Neutrophil paralysis in sepsis. Shock 34 Suppl 1: 15–21. doi: 10.1097/shk.0b013e3181e7e61b
[25]
Chishti AD, Shenton BK, Kirby JA, Baudouin SV (2004) Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med 30: 605–611. doi: 10.1007/s00134-004-2175-y
[26]
Cummings CJ, Martin TR, Frevert CW, Quan JM, Wong VA, et al. (1999) Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol 162: 2341–2346.
[27]
Rios-Santos F, Alves-Filho JC, Souto FO, Spiller F, Freitas A, et al. (2007) Down-regulation of CXCR2 on neutrophils in severe sepsis is mediated by inducible nitric oxide synthase-derived nitric oxide. Am J Respir Crit Care Med 175: 490–497. doi: 10.1164/rccm.200601-103oc
[28]
Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417: 1–13. doi: 10.1042/bj20081386
[29]
Galley HF (2010) Bench-to-bedside review: Targeting antioxidants to mitochondria in sepsis. Crit Care 14: 230.
[30]
Brealey D, Brand M, Hargreaves I, Heales S, Land J, et al. (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360: 219–223. doi: 10.1016/s0140-6736(02)09459-x
[31]
Huet O, Obata R, Aubron C, Spraul-Davit A, Charpentier J, et al. (2007) Plasma-induced endothelial oxidative stress is related to the severity of septic shock. Crit Care Med 35: 821–826. doi: 10.1097/01.ccm.0000257464.79067.af
[32]
Martins PS, Kallas EG, Neto MC, Dalboni MA, Blecher S, et al. (2003) Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock 20: 208–212. doi: 10.1097/01.shk.0000079425.52617.db
[33]
Martins PS, Brunialti MKC, Martos LSW, Machado FR, Assun？ao MS, et al. (2008) Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit care 12: R25. doi: 10.1186/cc6801
[34]
Kaufmann I, Hoelzl A, Schliephake F, Hummel T, Chouker A, et al. (2006) Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity. Shock 26: 254–261. doi: 10.1097/01.shk.0000223131.64512.7a
[35]
Sousa Santos S, Brunialti Colo MK, Rigato O, Machado FR, Silva E, et al. (2012) Generation of nitric oxide and reactive oxygen species by neutrophils and monocytes from septic patients and association with outcomes. Shock 38: 18–23. doi: 10.1097/shk.0b013e318257114e
[36]
Szabó C, Zingarelli B, O'Connor M, Salzman AL (1996) DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci 93: 1753–1758. doi: 10.1073/pnas.93.5.1753
[37]
Strand OA, Leone A, Giercksky KE, Kirkeb？en KA (2000) Nitric oxide indices in human septic shock. Crit Care Med 28: 2779–2785. doi: 10.1097/00003246-200008000-00017
[38]
Ohya M, Marukawa S, Inoue T, Ueno N, Hosohara K, et al. (2002) Plasma Nitrotyrosine Concentration Relates to Prognosis in Human Septic Shock. Shock 18: 116–118. doi: 10.1097/00024382-200208000-00004
[39]
Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 12: 646–652. doi: 10.1097/mco.0b013e3283312956
[40]
Eide DJ (2004) The SLC39 family of metal ion transporters. Pflugers Arch 447: 796–800. doi: 10.1007/s00424-003-1074-3
[41]
Wong HR, Cvijanovich N, Allen GL, Lin R, Meyer K, et al. (2009) Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 37: 1558–1566. doi: 10.1097/ccm.0b013e31819fcc08
[42]
Besecker BY, Exline MC, Hollyfield J, Phillips G, Disilvestro RA, et al. (2011) A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission. Am J Clin Nutr 93: 1356–1364. doi: 10.3945/ajcn.110.008417
[43]
Brunialti MKC, Martins PS, Barbosa de Carvalho H, Machado FR, Barbosa LM, et al. (2006) TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 25: 351–357. doi: 10.1097/01.shk.0000217815.57727.29
[44]
Parnell GP, Tang BM, Nalos M, Armstrong NJ, Huang SJ, et al. (2013) Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions. Shock 40: 166–174. doi: 10.1097/shk.0b013e31829ee604
[45]
Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, et al. (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85: 1341–1347. doi: 10.1007/978-1-4613-0391-6_77
[46]
Munoz C, Carlet J, Fitting C, Misset B, Blériot JP, et al. (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88: 1747–1754. doi: 10.1172/jci115493
[47]
Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, et al. (2011) A genomic storm in critically injured humans. J Exp Med 208: 2581–2590. doi: 10.1084/jem.20111354
